The organizers of the Rocky Mountain Life Science Investor Conference (RMLIC) have announced the selection of the final 13 of the 30 total companies which will present at the event to be held September 17 in Denver. The event – co-hosted by the Colorado Bioscience Association (CBSA) and the Arizona BioIndustry Organization (AZBio) with regional partners in Montana, Utah and New Mexico – seeks to bring together emerging companies from the Rocky Mountain Region together with a national group of investors and senior industry executives. Among the new additions are four Colorado-based companies, bringing Colorado’s total representation to 14 out of the 30 companies. Other presenting companies hail from Utah, Arizona, New Mexico, and Montana. The newly selected companies are (a list of the 17 first round selections is available here):
- Allogenesis (website coming soon) – Denver, CO
- Applied Microarrays, Inc. – Tempe, AZ
- Axial Biotech – Salt Lake City, UT
- Beacon Biotechnology – Aurora, CO
- Castle Biosciences – Phoenix, AZ
- Leap Frogg (website coming soon) – Grand Junction, CO
- LigoCyte Pharmaceuticals – Bozeman, MT
- Medipacs – Tucson, AZ
- NanoMR – Albuquerque, NM
- Numira Biosciences – Salt Lake City, UT
- PharmaJet – Golden, CO
- SenesTech, Inc. – Flagstaff, AZ
- Western States Biopharmaceuticals – Aurora, CO
For an in depth look at Beacon Biotechnology check out the RockyRadar profile.
